nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinapril—Hypertensive crisis—Sorafenib—liver cancer	0.0643	0.0644	CcSEcCtD
Quinapril—Cardiogenic shock—Epirubicin—liver cancer	0.0315	0.0315	CcSEcCtD
Quinapril—Cardiogenic shock—Doxorubicin—liver cancer	0.0291	0.0292	CcSEcCtD
Quinapril—Renal failure acute—Sorafenib—liver cancer	0.014	0.0141	CcSEcCtD
Quinapril—Dermatitis exfoliative—Sorafenib—liver cancer	0.0137	0.0138	CcSEcCtD
Quinapril—Breast disorder—Sorafenib—liver cancer	0.0117	0.0117	CcSEcCtD
Quinapril—Pancreatitis—Sorafenib—liver cancer	0.011	0.011	CcSEcCtD
Quinapril—Erectile dysfunction—Sorafenib—liver cancer	0.0103	0.0103	CcSEcCtD
Quinapril—Infestation—Sorafenib—liver cancer	0.00999	0.01	CcSEcCtD
Quinapril—Infestation NOS—Sorafenib—liver cancer	0.00999	0.01	CcSEcCtD
Quinapril—Acute coronary syndrome—Sorafenib—liver cancer	0.00985	0.00986	CcSEcCtD
Quinapril—Renal failure—Sorafenib—liver cancer	0.00982	0.00984	CcSEcCtD
Quinapril—Myocardial infarction—Sorafenib—liver cancer	0.00979	0.00981	CcSEcCtD
Quinapril—Hepatobiliary disease—Sorafenib—liver cancer	0.00945	0.00946	CcSEcCtD
Quinapril—Urinary tract disorder—Sorafenib—liver cancer	0.00886	0.00887	CcSEcCtD
Quinapril—Connective tissue disorder—Sorafenib—liver cancer	0.00881	0.00883	CcSEcCtD
Quinapril—Urethral disorder—Sorafenib—liver cancer	0.00879	0.00881	CcSEcCtD
Quinapril—Amblyopia—Epirubicin—liver cancer	0.00855	0.00856	CcSEcCtD
Quinapril—Cardiac disorder—Sorafenib—liver cancer	0.00832	0.00834	CcSEcCtD
Quinapril—Angiopathy—Sorafenib—liver cancer	0.00814	0.00815	CcSEcCtD
Quinapril—Immune system disorder—Sorafenib—liver cancer	0.0081	0.00811	CcSEcCtD
Quinapril—Mediastinal disorder—Sorafenib—liver cancer	0.00808	0.0081	CcSEcCtD
Quinapril—Arrhythmia—Sorafenib—liver cancer	0.00801	0.00802	CcSEcCtD
Quinapril—Alopecia—Sorafenib—liver cancer	0.00792	0.00794	CcSEcCtD
Quinapril—Amblyopia—Doxorubicin—liver cancer	0.00791	0.00792	CcSEcCtD
Quinapril—Mental disorder—Sorafenib—liver cancer	0.00786	0.00787	CcSEcCtD
Quinapril—Vasodilation procedure—Epirubicin—liver cancer	0.00751	0.00752	CcSEcCtD
Quinapril—Vasodilation—Epirubicin—liver cancer	0.00751	0.00752	CcSEcCtD
Quinapril—Viral infection—Epirubicin—liver cancer	0.00731	0.00732	CcSEcCtD
Quinapril—Angioedema—Sorafenib—liver cancer	0.00713	0.00715	CcSEcCtD
Quinapril—Syncope—Sorafenib—liver cancer	0.007	0.00701	CcSEcCtD
Quinapril—Vasodilation—Doxorubicin—liver cancer	0.00695	0.00696	CcSEcCtD
Quinapril—Vasodilation procedure—Doxorubicin—liver cancer	0.00695	0.00696	CcSEcCtD
Quinapril—Loss of consciousness—Sorafenib—liver cancer	0.00686	0.00687	CcSEcCtD
Quinapril—Cough—Sorafenib—liver cancer	0.00681	0.00682	CcSEcCtD
Quinapril—Viral infection—Doxorubicin—liver cancer	0.00676	0.00677	CcSEcCtD
Quinapril—Arthralgia—Sorafenib—liver cancer	0.00665	0.00666	CcSEcCtD
Quinapril—Myalgia—Sorafenib—liver cancer	0.00665	0.00666	CcSEcCtD
Quinapril—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.0066	0.00661	CcSEcCtD
Quinapril—Dry mouth—Sorafenib—liver cancer	0.0065	0.00651	CcSEcCtD
Quinapril—Hyperkalaemia—Epirubicin—liver cancer	0.00648	0.0065	CcSEcCtD
Quinapril—Anaphylactic shock—Sorafenib—liver cancer	0.00637	0.00638	CcSEcCtD
Quinapril—Infection—Sorafenib—liver cancer	0.00633	0.00634	CcSEcCtD
Quinapril—Shock—Sorafenib—liver cancer	0.00627	0.00628	CcSEcCtD
Quinapril—Nervous system disorder—Sorafenib—liver cancer	0.00625	0.00626	CcSEcCtD
Quinapril—Thrombocytopenia—Sorafenib—liver cancer	0.00624	0.00625	CcSEcCtD
Quinapril—Blood urea increased—Epirubicin—liver cancer	0.00623	0.00624	CcSEcCtD
Quinapril—Skin disorder—Sorafenib—liver cancer	0.00619	0.0062	CcSEcCtD
Quinapril—Hyperkalaemia—Doxorubicin—liver cancer	0.006	0.00601	CcSEcCtD
Quinapril—Musculoskeletal discomfort—Sorafenib—liver cancer	0.0058	0.00581	CcSEcCtD
Quinapril—Blood urea increased—Doxorubicin—liver cancer	0.00577	0.00577	CcSEcCtD
Quinapril—Dyspnoea—Sorafenib—liver cancer	0.00568	0.00569	CcSEcCtD
Quinapril—Dyspepsia—Sorafenib—liver cancer	0.00561	0.00562	CcSEcCtD
Quinapril—Gastrointestinal disorder—Sorafenib—liver cancer	0.0055	0.00551	CcSEcCtD
Quinapril—Fatigue—Sorafenib—liver cancer	0.00549	0.0055	CcSEcCtD
Quinapril—Constipation—Sorafenib—liver cancer	0.00545	0.00546	CcSEcCtD
Quinapril—Gastrointestinal pain—Sorafenib—liver cancer	0.00521	0.00522	CcSEcCtD
Quinapril—Renal failure acute—Epirubicin—liver cancer	0.00519	0.0052	CcSEcCtD
Quinapril—Dermatitis exfoliative—Epirubicin—liver cancer	0.00508	0.00509	CcSEcCtD
Quinapril—Abdominal pain—Sorafenib—liver cancer	0.00504	0.00505	CcSEcCtD
Quinapril—Anaphylactoid reaction—Epirubicin—liver cancer	0.00495	0.00496	CcSEcCtD
Quinapril—Cerebrovascular accident—Epirubicin—liver cancer	0.00489	0.0049	CcSEcCtD
Quinapril—Renal failure acute—Doxorubicin—liver cancer	0.0048	0.00481	CcSEcCtD
Quinapril—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.00479	0.0048	CcSEcCtD
Quinapril—Dermatitis exfoliative—Doxorubicin—liver cancer	0.0047	0.00471	CcSEcCtD
Quinapril—Anaphylactoid reaction—Doxorubicin—liver cancer	0.00458	0.00459	CcSEcCtD
Quinapril—Asthenia—Sorafenib—liver cancer	0.00457	0.00458	CcSEcCtD
Quinapril—Cerebrovascular accident—Doxorubicin—liver cancer	0.00452	0.00453	CcSEcCtD
Quinapril—Pruritus—Sorafenib—liver cancer	0.00451	0.00452	CcSEcCtD
Quinapril—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.00443	0.00444	CcSEcCtD
Quinapril—Liver function test abnormal—Epirubicin—liver cancer	0.00442	0.00443	CcSEcCtD
Quinapril—Orthostatic hypotension—Epirubicin—liver cancer	0.00438	0.00438	CcSEcCtD
Quinapril—Diarrhoea—Sorafenib—liver cancer	0.00436	0.00437	CcSEcCtD
Quinapril—Breast disorder—Epirubicin—liver cancer	0.00433	0.00434	CcSEcCtD
Quinapril—Dizziness—Sorafenib—liver cancer	0.00421	0.00422	CcSEcCtD
Quinapril—Liver function test abnormal—Doxorubicin—liver cancer	0.00409	0.0041	CcSEcCtD
Quinapril—Pancreatitis—Epirubicin—liver cancer	0.00406	0.00407	CcSEcCtD
Quinapril—Vomiting—Sorafenib—liver cancer	0.00405	0.00406	CcSEcCtD
Quinapril—Orthostatic hypotension—Doxorubicin—liver cancer	0.00405	0.00406	CcSEcCtD
Quinapril—Angina pectoris—Epirubicin—liver cancer	0.00403	0.00404	CcSEcCtD
Quinapril—Rash—Sorafenib—liver cancer	0.00402	0.00402	CcSEcCtD
Quinapril—Dermatitis—Sorafenib—liver cancer	0.00401	0.00402	CcSEcCtD
Quinapril—Breast disorder—Doxorubicin—liver cancer	0.00401	0.00401	CcSEcCtD
Quinapril—Headache—Sorafenib—liver cancer	0.00399	0.004	CcSEcCtD
Quinapril—Nausea—Sorafenib—liver cancer	0.00378	0.00379	CcSEcCtD
Quinapril—Photosensitivity reaction—Epirubicin—liver cancer	0.00378	0.00379	CcSEcCtD
Quinapril—Pancreatitis—Doxorubicin—liver cancer	0.00376	0.00376	CcSEcCtD
Quinapril—Angina pectoris—Doxorubicin—liver cancer	0.00373	0.00374	CcSEcCtD
Quinapril—Infestation NOS—Epirubicin—liver cancer	0.00369	0.0037	CcSEcCtD
Quinapril—Infestation—Epirubicin—liver cancer	0.00369	0.0037	CcSEcCtD
Quinapril—Renal failure—Epirubicin—liver cancer	0.00363	0.00364	CcSEcCtD
Quinapril—Urinary tract infection—Epirubicin—liver cancer	0.00359	0.00359	CcSEcCtD
Quinapril—Photosensitivity reaction—Doxorubicin—liver cancer	0.0035	0.0035	CcSEcCtD
Quinapril—Hepatobiliary disease—Epirubicin—liver cancer	0.00349	0.0035	CcSEcCtD
Quinapril—Agranulocytosis—Epirubicin—liver cancer	0.00345	0.00345	CcSEcCtD
Quinapril—Infestation NOS—Doxorubicin—liver cancer	0.00342	0.00342	CcSEcCtD
Quinapril—Infestation—Doxorubicin—liver cancer	0.00342	0.00342	CcSEcCtD
Quinapril—Renal failure—Doxorubicin—liver cancer	0.00336	0.00336	CcSEcCtD
Quinapril—Urinary tract infection—Doxorubicin—liver cancer	0.00332	0.00333	CcSEcCtD
Quinapril—Hepatitis—Epirubicin—liver cancer	0.00331	0.00332	CcSEcCtD
Quinapril—Pharyngitis—Epirubicin—liver cancer	0.00329	0.00329	CcSEcCtD
Quinapril—Urinary tract disorder—Epirubicin—liver cancer	0.00327	0.00328	CcSEcCtD
Quinapril—Connective tissue disorder—Epirubicin—liver cancer	0.00326	0.00326	CcSEcCtD
Quinapril—Urethral disorder—Epirubicin—liver cancer	0.00325	0.00325	CcSEcCtD
Quinapril—Hepatobiliary disease—Doxorubicin—liver cancer	0.00323	0.00324	CcSEcCtD
Quinapril—Agranulocytosis—Doxorubicin—liver cancer	0.00319	0.00319	CcSEcCtD
Quinapril—Eye disorder—Epirubicin—liver cancer	0.0031	0.0031	CcSEcCtD
Quinapril—Cardiac disorder—Epirubicin—liver cancer	0.00308	0.00308	CcSEcCtD
Quinapril—Hepatitis—Doxorubicin—liver cancer	0.00307	0.00307	CcSEcCtD
Quinapril—Pharyngitis—Doxorubicin—liver cancer	0.00304	0.00305	CcSEcCtD
Quinapril—Urinary tract disorder—Doxorubicin—liver cancer	0.00303	0.00303	CcSEcCtD
Quinapril—Connective tissue disorder—Doxorubicin—liver cancer	0.00301	0.00302	CcSEcCtD
Quinapril—Angiopathy—Epirubicin—liver cancer	0.00301	0.00301	CcSEcCtD
Quinapril—Urethral disorder—Doxorubicin—liver cancer	0.00301	0.00301	CcSEcCtD
Quinapril—Immune system disorder—Epirubicin—liver cancer	0.00299	0.003	CcSEcCtD
Quinapril—Mediastinal disorder—Epirubicin—liver cancer	0.00299	0.00299	CcSEcCtD
Quinapril—Arrhythmia—Epirubicin—liver cancer	0.00296	0.00297	CcSEcCtD
Quinapril—Alopecia—Epirubicin—liver cancer	0.00293	0.00293	CcSEcCtD
Quinapril—Mental disorder—Epirubicin—liver cancer	0.0029	0.00291	CcSEcCtD
Quinapril—Eye disorder—Doxorubicin—liver cancer	0.00287	0.00287	CcSEcCtD
Quinapril—Cardiac disorder—Doxorubicin—liver cancer	0.00285	0.00285	CcSEcCtD
Quinapril—Flatulence—Epirubicin—liver cancer	0.00284	0.00285	CcSEcCtD
Quinapril—Tension—Epirubicin—liver cancer	0.00283	0.00284	CcSEcCtD
Quinapril—Nervousness—Epirubicin—liver cancer	0.0028	0.00281	CcSEcCtD
Quinapril—Back pain—Epirubicin—liver cancer	0.00279	0.0028	CcSEcCtD
Quinapril—Angiopathy—Doxorubicin—liver cancer	0.00278	0.00279	CcSEcCtD
Quinapril—Immune system disorder—Doxorubicin—liver cancer	0.00277	0.00277	CcSEcCtD
Quinapril—Mediastinal disorder—Doxorubicin—liver cancer	0.00276	0.00277	CcSEcCtD
Quinapril—Arrhythmia—Doxorubicin—liver cancer	0.00274	0.00274	CcSEcCtD
Quinapril—Alopecia—Doxorubicin—liver cancer	0.00271	0.00271	CcSEcCtD
Quinapril—Mental disorder—Doxorubicin—liver cancer	0.00269	0.00269	CcSEcCtD
Quinapril—Ill-defined disorder—Epirubicin—liver cancer	0.00268	0.00268	CcSEcCtD
Quinapril—Flatulence—Doxorubicin—liver cancer	0.00263	0.00263	CcSEcCtD
Quinapril—Tension—Doxorubicin—liver cancer	0.00262	0.00262	CcSEcCtD
Quinapril—Malaise—Epirubicin—liver cancer	0.0026	0.00261	CcSEcCtD
Quinapril—Nervousness—Doxorubicin—liver cancer	0.00259	0.0026	CcSEcCtD
Quinapril—Vertigo—Epirubicin—liver cancer	0.00259	0.0026	CcSEcCtD
Quinapril—Syncope—Epirubicin—liver cancer	0.00259	0.00259	CcSEcCtD
Quinapril—Back pain—Doxorubicin—liver cancer	0.00258	0.00259	CcSEcCtD
Quinapril—Palpitations—Epirubicin—liver cancer	0.00255	0.00255	CcSEcCtD
Quinapril—Loss of consciousness—Epirubicin—liver cancer	0.00254	0.00254	CcSEcCtD
Quinapril—Cough—Epirubicin—liver cancer	0.00252	0.00252	CcSEcCtD
Quinapril—Ill-defined disorder—Doxorubicin—liver cancer	0.00248	0.00248	CcSEcCtD
Quinapril—Arthralgia—Epirubicin—liver cancer	0.00246	0.00246	CcSEcCtD
Quinapril—Chest pain—Epirubicin—liver cancer	0.00246	0.00246	CcSEcCtD
Quinapril—Myalgia—Epirubicin—liver cancer	0.00246	0.00246	CcSEcCtD
Quinapril—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.00244	0.00244	CcSEcCtD
Quinapril—Discomfort—Epirubicin—liver cancer	0.00243	0.00243	CcSEcCtD
Quinapril—Malaise—Doxorubicin—liver cancer	0.00241	0.00241	CcSEcCtD
Quinapril—Dry mouth—Epirubicin—liver cancer	0.0024	0.00241	CcSEcCtD
Quinapril—Vertigo—Doxorubicin—liver cancer	0.0024	0.0024	CcSEcCtD
Quinapril—Syncope—Doxorubicin—liver cancer	0.00239	0.0024	CcSEcCtD
Quinapril—Palpitations—Doxorubicin—liver cancer	0.00236	0.00236	CcSEcCtD
Quinapril—Anaphylactic shock—Epirubicin—liver cancer	0.00235	0.00236	CcSEcCtD
Quinapril—Oedema—Epirubicin—liver cancer	0.00235	0.00236	CcSEcCtD
Quinapril—Loss of consciousness—Doxorubicin—liver cancer	0.00235	0.00235	CcSEcCtD
Quinapril—Infection—Epirubicin—liver cancer	0.00234	0.00234	CcSEcCtD
Quinapril—Cough—Doxorubicin—liver cancer	0.00233	0.00233	CcSEcCtD
Quinapril—Shock—Epirubicin—liver cancer	0.00232	0.00232	CcSEcCtD
Quinapril—Nervous system disorder—Epirubicin—liver cancer	0.00231	0.00231	CcSEcCtD
Quinapril—Thrombocytopenia—Epirubicin—liver cancer	0.00231	0.00231	CcSEcCtD
Quinapril—Tachycardia—Epirubicin—liver cancer	0.0023	0.0023	CcSEcCtD
Quinapril—Skin disorder—Epirubicin—liver cancer	0.00229	0.00229	CcSEcCtD
Quinapril—Hyperhidrosis—Epirubicin—liver cancer	0.00228	0.00228	CcSEcCtD
Quinapril—Chest pain—Doxorubicin—liver cancer	0.00227	0.00228	CcSEcCtD
Quinapril—Arthralgia—Doxorubicin—liver cancer	0.00227	0.00228	CcSEcCtD
Quinapril—Myalgia—Doxorubicin—liver cancer	0.00227	0.00228	CcSEcCtD
Quinapril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.00226	0.00226	CcSEcCtD
Quinapril—Discomfort—Doxorubicin—liver cancer	0.00225	0.00225	CcSEcCtD
Quinapril—Dry mouth—Doxorubicin—liver cancer	0.00222	0.00223	CcSEcCtD
Quinapril—Anaphylactic shock—Doxorubicin—liver cancer	0.00218	0.00218	CcSEcCtD
Quinapril—Oedema—Doxorubicin—liver cancer	0.00218	0.00218	CcSEcCtD
Quinapril—Infection—Doxorubicin—liver cancer	0.00216	0.00217	CcSEcCtD
Quinapril—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00215	0.00215	CcSEcCtD
Quinapril—Shock—Doxorubicin—liver cancer	0.00214	0.00215	CcSEcCtD
Quinapril—Nervous system disorder—Doxorubicin—liver cancer	0.00214	0.00214	CcSEcCtD
Quinapril—Thrombocytopenia—Doxorubicin—liver cancer	0.00213	0.00214	CcSEcCtD
Quinapril—Insomnia—Epirubicin—liver cancer	0.00213	0.00213	CcSEcCtD
Quinapril—Tachycardia—Doxorubicin—liver cancer	0.00213	0.00213	CcSEcCtD
Quinapril—Skin disorder—Doxorubicin—liver cancer	0.00212	0.00212	CcSEcCtD
Quinapril—Paraesthesia—Epirubicin—liver cancer	0.00211	0.00212	CcSEcCtD
Quinapril—Hyperhidrosis—Doxorubicin—liver cancer	0.00211	0.00211	CcSEcCtD
Quinapril—Dyspnoea—Epirubicin—liver cancer	0.0021	0.0021	CcSEcCtD
Quinapril—Somnolence—Epirubicin—liver cancer	0.00209	0.0021	CcSEcCtD
Quinapril—Dyspepsia—Epirubicin—liver cancer	0.00207	0.00208	CcSEcCtD
Quinapril—Gastrointestinal disorder—Epirubicin—liver cancer	0.00203	0.00204	CcSEcCtD
Quinapril—Fatigue—Epirubicin—liver cancer	0.00203	0.00203	CcSEcCtD
Quinapril—Constipation—Epirubicin—liver cancer	0.00201	0.00202	CcSEcCtD
Quinapril—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00198	0.00199	CcSEcCtD
Quinapril—Insomnia—Doxorubicin—liver cancer	0.00197	0.00197	CcSEcCtD
Quinapril—Paraesthesia—Doxorubicin—liver cancer	0.00196	0.00196	CcSEcCtD
Quinapril—Dyspnoea—Doxorubicin—liver cancer	0.00194	0.00195	CcSEcCtD
Quinapril—Feeling abnormal—Epirubicin—liver cancer	0.00194	0.00194	CcSEcCtD
Quinapril—Somnolence—Doxorubicin—liver cancer	0.00194	0.00194	CcSEcCtD
Quinapril—Gastrointestinal pain—Epirubicin—liver cancer	0.00193	0.00193	CcSEcCtD
Quinapril—Dyspepsia—Doxorubicin—liver cancer	0.00192	0.00192	CcSEcCtD
Quinapril—Gastrointestinal disorder—Doxorubicin—liver cancer	0.00188	0.00188	CcSEcCtD
Quinapril—Fatigue—Doxorubicin—liver cancer	0.00188	0.00188	CcSEcCtD
Quinapril—Constipation—Doxorubicin—liver cancer	0.00186	0.00187	CcSEcCtD
Quinapril—Abdominal pain—Epirubicin—liver cancer	0.00186	0.00186	CcSEcCtD
Quinapril—Feeling abnormal—Doxorubicin—liver cancer	0.0018	0.0018	CcSEcCtD
Quinapril—Gastrointestinal pain—Doxorubicin—liver cancer	0.00178	0.00178	CcSEcCtD
Quinapril—Abdominal pain—Doxorubicin—liver cancer	0.00172	0.00173	CcSEcCtD
Quinapril—Asthenia—Epirubicin—liver cancer	0.00169	0.00169	CcSEcCtD
Quinapril—Benazepril—MTHFR—liver cancer	0.00167	1	CrCbGaD
Quinapril—Pruritus—Epirubicin—liver cancer	0.00167	0.00167	CcSEcCtD
Quinapril—Diarrhoea—Epirubicin—liver cancer	0.00161	0.00161	CcSEcCtD
Quinapril—Asthenia—Doxorubicin—liver cancer	0.00156	0.00157	CcSEcCtD
Quinapril—Dizziness—Epirubicin—liver cancer	0.00156	0.00156	CcSEcCtD
Quinapril—Pruritus—Doxorubicin—liver cancer	0.00154	0.00154	CcSEcCtD
Quinapril—Vomiting—Epirubicin—liver cancer	0.0015	0.0015	CcSEcCtD
Quinapril—Diarrhoea—Doxorubicin—liver cancer	0.00149	0.00149	CcSEcCtD
Quinapril—Rash—Epirubicin—liver cancer	0.00148	0.00149	CcSEcCtD
Quinapril—Dermatitis—Epirubicin—liver cancer	0.00148	0.00149	CcSEcCtD
Quinapril—Headache—Epirubicin—liver cancer	0.00148	0.00148	CcSEcCtD
Quinapril—Dizziness—Doxorubicin—liver cancer	0.00144	0.00144	CcSEcCtD
Quinapril—Nausea—Epirubicin—liver cancer	0.0014	0.0014	CcSEcCtD
Quinapril—Vomiting—Doxorubicin—liver cancer	0.00139	0.00139	CcSEcCtD
Quinapril—Rash—Doxorubicin—liver cancer	0.00137	0.00138	CcSEcCtD
Quinapril—Dermatitis—Doxorubicin—liver cancer	0.00137	0.00137	CcSEcCtD
Quinapril—Headache—Doxorubicin—liver cancer	0.00136	0.00137	CcSEcCtD
Quinapril—Nausea—Doxorubicin—liver cancer	0.00129	0.0013	CcSEcCtD
